Search
Menu
Vescent Photonics LLC - Lasers, Combs, Controls 4/15-5/15 LB

QuantRx Biomed Begins Blood Imaging Trials

Facebook X LinkedIn Email
QuantRx Biomedical Corp. of Doylestown, Pa., has announced that Phase 1 trials have begun for the BFPET blood flow imaging agent for PET. An affiliated company, FluoroPharma Inc. of Boston will evaluate the safety, distribution and dosimetry of the agent for myocardial perfusion imaging in healthy subjects.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: May 2008
    Biophotonicsblood flowenergymyocardial perfusion imagingNews & FeaturesQuantRx Biomedical Corp.

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.